NCT06488274招募中不适用
Assessment of the Evolution of functIonal Gastrointestinal Disorders in Infants During Their Dietary Management With a New Infant Formula
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 139
- 试验地点
- 4
- 主要终点
- Change from baseline of the Gastrointestinal and Gastroesophageal Reflux (GIGER) scale score
研究概览
简要总结
This study aims to assess the evolution of functional gastrointestinal disorders (FGIDs) in infants fed with a new infant formula, using the Gastrointestinal (GI) and gastroesophageal reflux (GER) (GIGER) scale through an interventional, open-label, non-comparative multicenter study.
详细描述
The study comprises a first period of 30 days followed by an optional intervention period of 90 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- — 至 4 Months（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Infants presenting with at least one of the FGIDs below, defined based on adapted Rome IV criteria as follows:
- •1.1 Regurgitations: 1.2 Colic: 1.3 Constipation:
- •Infants born at 35 weeks or more of gestational age
- •Infants up to 4 months of age
排除标准
- •Exclusively or partially breastfed infants (i.e. > 2 breast feeds per day) with maternal willingness to continue breastfeeding
- •Diversified infants or whose parents intend to start diversification within the first 2 weeks of the study
- •Use of antibiotics at inclusion visit (V0) and within 7 days before the inclusion visit (V0)
- •The willingness to take additional pre-, probiotics or thickening agents during the study
- •Known allergy/intolerance to any of the product ingredients or suspected allergy to cow's milk requiring an eviction diet
- •Infants presenting with any other situation including the participation in another clinical trial, which, according to the investigator, may interfere with the study participation, or lead to a particular risk for the patient
- •(non exhaustive list)
研究组 & 干预措施
Test formula
Experimental
The test product is a thickened infant formula containing symbiotic (fibers and probiotics)
干预措施: New infant formula (Dietary Supplement)
结局指标
主要结局
Change from baseline of the Gastrointestinal and Gastroesophageal Reflux (GIGER) scale score
时间窗: Day 30
The main outcome will be the evolution of the sum score of the Gastrointestinal and Gastroesophageal Reflux (GIGER) scale (Pados et al., 2021). The GIGER score varies from 0 to 180 being the worst.
次要结局
- Investigator's evaluation of the evolution of FGIDs(Day 14, Day 30, Day 60, Day 90, Day 120)
- Regurgitation severity(Day 14, Day 30, Day 60, Day 90, Day 120)
- Stool frequency and consistency in non constipated infant(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Stool frequency and consistency in constipated infant(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Colic(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Abdominal distension severity(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- GIGER score(Day 7, Day 14, Day 60, Day 90, Day 120)
- Number of bottles at night(D7, D14, D30, D60, D90, D120)
- Parents' satisfaction(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Regurgitation frequency(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Weight(Day 30, Day 60, Day 90, Day 120)
- Height(Day 30, Day 60, Day 90, Day 120)
- Gas/flatulence severity(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- BMI(Day 30, Day 60, Day 90, Day 120)
- Evolution of FGIDs (regurgitations, colic and constipation)(Day 14, Day 30, Day 60, Day 90, Day 120)
- Defecation pain frequency in constipated infant(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Infant's quality of life(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Adverse events(Through study completion (up to 30 days or 120 days if participation to the optional intervention period))
- Sleep(Day 7, Day 14, Day 30, Day 60, Day 90, Day 120)
- Head circumference(Day 30, Day 60, Day 90, Day 120)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Functional Gastrointestinal Disorders in Pediatric IBDPediatric DisorderFunctional Gastrointestinal DisordersInflammatory Bowel DiseasesQuality of LifeAnxiety DepressionNCT03565263University Hospital, Caen350
尚未招募
不适用
Prevalence and Associated Factors of Functional Gastrointestinal Disorders Among ChildrenFunctional Gastrointestinal DisordersNCT05605405Assiut University269
招募中
不适用
Evaluation of functional gastrointestinal disorders in a group of bariatric patientsE66.12K59R15Other functional intestinal disordersFaecal incontinenceDRKS00009268niversitätsklinikum Mannheim270
已完成
不适用
Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in ThailandFunctional Gastrointestinal DisordersNCT03608735Danone Asia Pacific Holdings Pte, Ltd.7,908
Unknown
不适用
Frequency of Functional Gastrointestinal Disorders in ChildrenFunctional Abdominal Pain SyndromeNCT04320550Assiut University246